These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 7226875

  • 1. A multi-centre general practice study on the use of a timolol/bendrofluazide combination ('Prestim') in the management of hypertension: preliminary report.
    Langrick AF, Head AC.
    Curr Med Res Opin; 1981; 7(4):268-75. PubMed ID: 7226875
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prestim in the management of mild to moderate essential hypertension in general practice.
    Peacock K, Hodge B.
    J Int Med Res; 1983; 11(3):186-9. PubMed ID: 6347751
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A post-marketing acceptability study in 11,685 patients of the efficacy of timolol/bendrofluazide in the management of hypertension in general practice.
    Marsh BT, Atkins MJ, Talbot DJ, Fairey IT.
    J Int Med Res; 1987; 15(2):106-14. PubMed ID: 3582721
    [Abstract] [Full Text] [Related]

  • 9. The use of timolol/bendrofluazide (Prestim) in the treatment of hypertensive patients failing to respond to other antihypertensives.
    Ellis R, Wood SJ.
    J Int Med Res; 1983; 11(6):359-63. PubMed ID: 6140195
    [Abstract] [Full Text] [Related]

  • 10. The management vf essential hypertension with once daily administration of timolol maleate and bendrofluazide.
    Deering RB, Fox AS, Ison LJ.
    J Int Med Res; 1977; 5(2):114-9. PubMed ID: 326593
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Contribution of atenolol, bendrofluazide, and hydrallazine to management of severe hypertension.
    Wilcox RG, Mitchell JR.
    Br Med J; 1977 Aug 27; 2(6086):547-50. PubMed ID: 329948
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of a fixed combination of timolol maleate, hydrochlorothiazide and amiloride hydrochloride in the treatment of hypertension: A long-term multicentre trial.
    Pittaway D.
    S Afr Med J; 1980 Aug 09; 58(6):231-5. PubMed ID: 6996156
    [Abstract] [Full Text] [Related]

  • 18. Amelioration of bendrofluazide-induced hypokalemia by timolol.
    Hettiarachchi J, Ramsay LE, Davies DL, Fraser R, Watson WS.
    Clin Pharmacol Ther; 1977 Jul 09; 22(1):58-62. PubMed ID: 326460
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [The anti-hypertensive effect of timolol maleate (blocadren) in gradated combination with a diuretic].
    Vorburger C.
    Schweiz Med Wochenschr; 1976 Oct 23; 106(43):1474-81. PubMed ID: 1013666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.